Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 6, 2007, Pages 799-803

  Sanghvi, Neil K ^a,b   Tracy, Cynthia M ^a  

^a GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Apical aneurysm; Apical hypertrophic cardiomyopathy; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

ADULT; ANEURYSM; CASE REPORT; DEFIBRILLATOR; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MORTALITY; PREVALENCE; REVIEW; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; HEART ANEURYSM; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 34249824248     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00753.x     Document Type: Review

References (34)

1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997 336: 775 785.
2. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ 2006 332: 1251 1255.
3. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114: e385 e484.
4. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006 113: e858 e862.
5. Falicov RE, Resnekov L, Bharati S, Lev M. Mid-ventricular obstruction: A variant of obstructive cardiomyopathy. Am J Cardiol 1976 37: 432 437.
6. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989 320: 749 755.
7. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000 36: 2212 2218.
8. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003 42: 1687 1713.
9. Mantica M, Della Bella P, Arena V. Hypertrophic cardiomyopathy with apical aneurysm: A case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia. Heart 1997 77: 481 483.
10. Inoue T, Sunagawa O, Tohma T, Shinzato Y, Fukiyama K. Apical hypertrophic cardiomyopathy followed by midventricular obstruction and apical aneurysm: A case report. J Cardiol 1999 33: 217 222.
11. Begley D, Mohiddin S, Fananapazir L. Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2001 24: 1639 1644.
12. Akutsu Y, Shinozuka A, Huang TY, Watanabe T, Yamada T, Yamanaka H, Saitou T, et al. Hypertrophic cardiomyopathy with apical left ventricular aneurysm. Jpn Circ J 1998 62: 127 131.
13. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003 42: 288 295.
14. Nakamura T, Matsubara K, Furukawa K, Azuma A, Sugihara H, Katsume H, Nakagawa M. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: Evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 1992 19: 516 524.
15. Zoghbi WA, Haichin RN, Quinones MA. Mid-cavity obstruction in apical hypertrophy: Doppler evidence of diastolic intraventricular gradient with higher apical pressure. Am Heart J 1988 116: 1469 1474.
16. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002 39: 638 645.
17. Wilson P, Marks A, Rastegar H, Manolis AS, Estes NA, 3rd. Apical hypertrophic cardiomyopathy presenting with sustained monomorphic ventricular tachycardia and electrocardiographic changes simulating coronary artery disease and left ventricular aneurysm. Clin Cardiol 1990 13: 885 887.
18. Ridjab D, Koch M, Zabel M, Schultheiss HP, Morguet AJ. Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy. Cardiology 2006 107: 81 86.
19. Kono K, Higashi T, Hara K, Mori S, Ito I, Shinbo G, Anzai R, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: A case report. J Cardiol 2001 38: 343 349.
20. Mitchell MA, Nath S, Thompson KA, Pagley PR, DiMarco JP. Sustained wide complex tachycardia resulting in myocardial injury in a patient with apical hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1997 20: 1866 1869.
21. Okishige K, Sasano T, Yano K, Azegami K, Suzuki K, Itoh K. Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern Med 2001 40: 396 402.
22. Doi YL, Hamashige N, Yonezawa Y, Ozawa T. Apical hypertrophic cardiomyopathy and ventricular tachycardia. Eur Heart J 1984 5: 824 828.
23. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997 350: 127 133.
24. Sherrid MV, Pearle G, Gunsburg DZ. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998 97: 41 47.
25. Niki K, Sugawara M, Asano R, Oka T, Kondoh Y, Tanino S, Iwade K, et al. Disopyramide improves the balance between myocardial oxygen supply and demand in patients with hypertrophic obstructive cardiomyopathy. Heart Vessels 1997 12: 111 118.
26. Hongo M, Nakatsuka T, Takenaka H, Tanaka M, Watanabe N, Yazaki Y, Sekiguchi M. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy. Cardiology 1996 87: 6 11.
27. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985 53: 412 416.
28. McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, Oakley CM, Goodwin JF. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol 1984 54: 802 810.
29. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population. Heart 1998 79: 331 336.
30. Mirowski M, Mower MM, Reid PR, Watkins L, Langer A. The automatic implantable defibrillator. New modality for treatment of life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 1982 5: 384 401.
31. Maron BJ, Shen WK, Link MS, Epstein AE, Almguist AK, Daubert JP, Bardy GH, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342: 365 373.
32. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997 337: 1576 1583.
33. Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, et al. Canadian Implantable Defibrillator Study (CIDS): Study design and organization. CIDS Co-Investigators. Am J Cardiol 1993 72: 103F 108F.
34. Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999 33: 1596 1601.